Acasti Pharma Buy Hold or Sell Recommendation

ACSTDelisted Stock  USD 3.37  0.01  0.30%   
Given the investment horizon of 90 days and your bold attitude towards risk, our recommendation regarding Acasti Pharma is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Acasti Pharma given historical horizon and risk tolerance towards Acasti Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Acasti Pharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Note, we conduct extensive research on individual companies such as Acasti and provide practical buy, sell, or hold advice based on investors' constraints. Acasti Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Execute Acasti Pharma Buy or Sell Advice

The Acasti recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Acasti Pharma. Macroaxis does not own or have any residual interests in Acasti Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Acasti Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Acasti PharmaBuy Acasti Pharma
Not Rated
For the selected time horizon Acasti Pharma has a Risk Adjusted Performance of 0.0704, Jensen Alpha of 0.2957, Total Risk Alpha of (0.34), Sortino Ratio of 0.0722 and Treynor Ratio of 0.8462
We provide trade advice to complement the prevailing expert consensus on Acasti Pharma. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Acasti Pharma is not overpriced, please confirm all Acasti Pharma fundamentals, including its total debt, market capitalization, and the relationship between the gross profit and short ratio . Given that Acasti Pharma has a price to book of 0.58 X, we suggest you to validate Acasti Pharma market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Acasti Pharma Trading Alerts and Improvement Suggestions

Acasti Pharma is now traded under the symbol GRCE. Please update your portfolios or report it if you believe this is an error. Report It!
Acasti Pharma is not yet fully synchronised with the market data
Acasti Pharma appears to be risky and price may revert if volatility continues
Acasti Pharma has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (12.85 M) with profit before overhead, payroll, taxes, and interest of 120 K.
Acasti Pharma currently holds about 38.39 M in cash with (12.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86.
Roughly 38.0% of the company shares are held by company insiders

Acasti Pharma Returns Distribution Density

The distribution of Acasti Pharma's historical returns is an attempt to chart the uncertainty of Acasti Pharma's future price movements. The chart of the probability distribution of Acasti Pharma daily returns describes the distribution of returns around its average expected value. We use Acasti Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Acasti Pharma returns is essential to provide solid investment advice for Acasti Pharma.
Mean Return
0.35
Value At Risk
-3.85
Potential Upside
9.42
Standard Deviation
4.38
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Acasti Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Olds Donald of 12500 shares of Acasti Pharma at 2.64 subject to Rule 16b-3 [view details]

Acasti Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Acasti . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Acasti Pharma Buy or Sell Advice

When is the right time to buy or sell Acasti Pharma? Buying financial instruments such as Acasti Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Acasti Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Broad Equity ETFs Thematic Idea Now

Broad Equity ETFs
Broad Equity ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 479 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Acasti Stock

If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stocks Directory
Find actively traded stocks across global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities